All trademarks mentioned are the property of their respective owners. Check out Regeneron salary trends by job title, compare the salaries with National Average and Average salaries at the company. From March 2011 to August 2016, he served as the President of The Rockefeller University. Mr. LaRosa received his JD degree from New York University. Salaries at Regeneron Inc range from an average of $56,988 to $166,375 a year. Careers at Regeneron | Regeneron Job … Prior to joining Regeneron, Dr. Lowy was at Medarex for eight years. Dr. He has held prior positions at Regeneron in Quality Control and Analytical Sciences, and prior to joining Regeneron, worked at Abbott Laboratories conducting diagnostic assay R&D, bio-process development and commercial assay kit manufacturing. Google may share that information with third parties if Google is obliged to do so by law or to the extent such third parties are processing this information on behalf of Google. Prior to joining Regeneron, she was Chief Business Officer of Constellation Pharmaceuticals. Dr. Bassler has previously served as the President of the American Society for Microbiology, as well as on the boards for the American Association for the Advancement of Science, the National Science Foundation and the American Academy of Microbiology. Dr. Zambrowicz received his BS from the University of Wisconsin-Madison and his PhD from the University of Washington. He also previously served as Vice President, Global Compliance and Legal Affairs at Avon Products, Inc., and held a number of senior legal positions at Schering-Plough Corporation, where he was a corporate officer and served as Vice President, Legal Affairs, and a member of the Operations Management Team. Full-time; New York, NY, US; Posted 8 mins ago; Website Regeneron. She previously held roles at Regeneron in Preclinical Manufacturing and Process Development, Process Sciences and Combination Products. She received her BA from Harvard University and her JD from New York University. Industrial Operations and Product Supply at Regeneron Pharmaceuticals Most recently she was VP, Global Head of DE&I at Zendesk. Mr. Husseini received his undergraduate degree in Molecular Biology from Princeton University and MBA from the Wharton School at University of Pennsylvania. He has nearly 20 years of experience in the biopharmaceutical industry, where he has held a variety of strategic, business development and finance roles, including in Genentech’s Business Development and Corporate Finance departments and in investment banking and equity research at Morgan Stanley and Robertson Stephens. How does this position fit into your career goals? He earned his MBA with the UK Open University and holds a degree in Electrical Engineering. He previously held roles in Process Development and Preclinical Manufacturing, Clinical Manufacturing, and Manufacturing Sciences. Gerald Carreau joined Regeneron in 2008 and serves as Senior Vice President, Commercial Scale Manufacturing and Manufacturing Technology. Dr. Bak received her BS, MS and PhD in Chemical Engineering from Danmarks Tekniske Universitet (Technical University of Denmark). Mr. Fenimore holds an MA in Biotechnology from Columbia University, an MBA in Professional Accounting from Rutgers Business School and a BA in Economics from Rutgers University. Prior to joining Regeneron, Ms. McCourt worked at Axovant, a clinical-stage biopharmaceutical company, where she was President and Chief Operating Officer. Compare pay for popular roles and read about the team’s work-life balance. Prior to joining Regeneron, Mr. LaRosa was Senior Vice President, General Counsel and Secretary at Nycomed U.S., Inc. She served as Chief Operating Officer of Medivation until it was acquired by Pfizer Inc. in 2016, and before that held commercial leadership roles at Amgen, including Vice President in U.S. Commercial Operations and Vice President and General Manager responsible for the company’s bone health and primary care business unit. Jennifer McNay, PhD, joined Regeneron in 2000 and serves as Senior Vice President of Chemistry, Manufacturing and Controls (CMC) Regulatory Sciences and Industrial Affairs. He completed his medical residency at North Shore Long Island Jewish (LIJ) Health System and conducted post doctorate work at Columbia University. Prior to joining Pfizer, Ms. Mirza was Managing Director at W2O Group, a leading healthcare communications agency. Patrice Gilooly joined Regeneron in 1998 and serves as Senior Vice President, Quality Assurance and Operations. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Deborah Tegan joined Regeneron in 2006 and serves as Senior Vice President, Strategic Sourcing and Procurement. Prior to joining Regeneron, Dr. Lancaster served as Chief Medical Officer at Myriad Genetics, Inc., following more than a decade in academics at Moffitt Comprehensive Cancer Center in Tampa as a gynecologic oncologist, molecular genetics researcher, and ultimately President of the Moffitt Medical Group Corporation. William Olson, PhD, joined Regeneron in 2013 as Vice President and now serves as Senior Vice President of Therapeutic Proteins, where he is responsible for antibody generation, a key component of drug discovery, through innovative technologies. Dr. McNay earned her BS in Chemical Engineering from the University of Delaware and her MS and PhD in Chemical Engineering from the University of Virginia. Apply to Quality Control Supervisor, Quality Assurance Analyst, Process Technician and more! Dr. Brown and Dr. Joseph Goldstein jointly received the Nobel Prize for Physiology or Medicine in 1985 and the U.S. National Medal of Science in 1988. Previously, he served as Executive Vice President and Chief Scientific Officer at Genentech, Inc., which he joined in 2003. Previously, he worked at Pfizer for 10 years focusing on research and early development of biologics, and before that he worked at Rinat Neuroscience Corporation after completing his postdoctoral fellowship at Genentech. Find more at Careerbliss.com. Dr. Vagelos was on the Board of Directors of Theravance, Inc. through April 2010. Mr. Fenimore is a Certified Public Accountant in the State of New York. Made up of our founding scientists, industry experts, Nobel Laureates and members of the National Academy of Sciences, we consistently push the boundaries of scientific excellence and discovery. She has been elected to the National Academy of Sciences, the Institute of Medicine and the American Association for the Advancement of Science, and has been awarded numerous recognitions for her work, including the Pearl Meister Greengard Prize, the March of Dimes Prize in Developmental Biology and the Vanderbilt Prize in Biomedical Science. Before joining Regeneron, Dr. Sirulnik was Chief Medical Officer at Merus N.V., a clinical-stage immuno-oncology company. Find out what works well at Regeneron from the people who know best. Find 103 questions and answers about working at Regeneron. Mr. O’Leary received his BS in Biotechnology from Dublin City University, Ireland and his MBA from the Williams College of Business at Xavier University in Cincinnati, Ohio. Browse our opportunities and apply today to a Regeneron general-and-administrative position. Prior to joining Regeneron, Dr. Murphy worked for seven years at Cadus Pharmaceuticals. Leonard S. Schleifer, MD, PhD, founded Regeneron in 1988, has been a Director and the company's President and Chief Executive Officer since its inception. Brian Zambrowicz, PhD, joined Regeneron in 2015 and serves as Senior Vice President, Functional Genomics and Chief VelociGene® Operations. Our robust research and development engine allows us to discover therapies that could have a profound impact on patient health. Ron Wang, PhD, joined Regeneron in 1999 and currently serves as Senior Vice President of Quality Control, leading a global function that leverages strategic business partnerships and automation to provide back-up lab capabilities, protect the supply chain and optimize resources and lab capacity. Regeneron has no influence on such use. Our FDA-approved medicines are only the beginning of our long-term commitment to solve the human body's most complex mysteries. We do not interview candidates on Google Hangouts. Len discusses his motivation for starting the company, Len and George reflect on their partnership, Neil explains why he joined the Regeneron team, Daniel's perspective on why Regeneron is unique, Len, George and Roy discuss how Len recruited Roy. He began his education at the Bronx High School of Science, received his MD and PhD from Columbia University and went on to become the 11th most highly cited scientist in the world in the 1990s. Before joining Regeneron, Mr. Underwood worked at Fluor Daniel, the Jacobs Engineering Group and Day Laboratories. Dr. Weinreich was previously the Senior Vice President and Head of Global Development for Specialty Medicine at Bayer Pharmaceuticals. Ms. McCourt began her career and spent 12 years at AstraZeneca, ultimately becoming Chief Operating Officer for AstraZeneca U.S. She received her BS from Lafayette College. He has driven an enhanced company focus on big data, innovation and strategic IT investments that support Regeneron’s mission. Gavin Thurston, PhD, joined Regeneron in 2001 initially to study the interaction of the VEGF signaling pathway with other angiogenic pathways and to target these pathways for the treatment of cancer. Bari Kowal joined Regeneron in 2015 and became Head of Global Clinical Operations in 2017. Prior to joining Regeneron, Dr. Merino was an Associate General Counsel at Columbia University and a patent attorney at Bryan Cave LLP in New York City. Ms. Pillai has an accomplished global DE&I career spanning Life Sciences, Technology, Financial Services and Media sectors. Between 2004 and 2006, Mr. Van Plew held positions of increasing responsibility at Chiron Biopharmaceuticals, most recently as Senior Director, Vacaville Operations. She served as a Postdoctoral Fellow and Research Scientist at the Agouron Institute in La Jolla, CA, before becoming a faculty member at Princeton University. The site you are about to visit is maintained by a third party who is solely responsible for its content. Ms. Tegan received her BS and MBA from Iona College. Prior to joining Onyx in 2008, he was President, Chief Executive Officer, and a member of the board of directors of NPS Pharmaceuticals, Inc., a biopharmaceutical company. We use Google Analytics cookie service to track and obtain reports on how visitors are using the Sites. CareerBliss Login; Join ... -$35K (47%) less than national average IT Project Manager salary ($91K)-$4K (6%) less than average Regeneron salary ($60K) $50K. Prior to joining Regeneron, Mr. Landry served as Senior Vice President and Treasurer of Pfizer Inc. Mr. Landry also held a variety of U.S. and international financial and general management positions at Wyeth Pharmaceuticals, Pfizer and PricewaterhouseCoopers LLP, including at Wyeth's Australian and New Zealand affiliates. Prior to joining Regeneron, he was at University of California, San Francisco studying tumor vascular biology. Ms. Bermingham and her Washington, DC-based team play a critical role in helping Regeneron shape and maintain its industry-leading reputation among governmental stakeholders. We encourage you to read the privacy policy of every website you visit. Dr. Yancopoulos is currently President and Chief Scientific Officer and has served on the board since 2001. Joseph L. Goldstein, MD, has been a Director of the company since June 1991. Before that, she has led global marketing research, corporate strategy and DE&I efforts at Fortune 50 companies such as Prudential Financial, Johnson & Johnson and ACNielsen. Dr. Bassler received her BSc from the University of California, Davis, and her PhD in Biochemistry from Johns Hopkins University. Continue Reading Before joining Regeneron, she was Vice President, Corporate Affairs for R&D and Strategy at Pfizer Inc. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media. next and final interview is with hiring manager (s) where they ask about your past experience and questions relevant to the job position. Dr. Yancopoulos is currently President and Chief Scientific Officer and has served on … Ms. Mirza received her BA from The George Washington University. Join our team and help turn science into life-changing medicine. We'll be in touch soon. She was previously Executive Vice President, Chief Human Resources Officer at Inova Health System. Dr. Yancopoulos has been driven by science his entire life. Niall O’Leary joined Regeneron in 2012 and serves as Senior Vice President and Site Head of IOPS Raheen. The information obtained with this cookie, which includes the IP address of your computer, will be transmitted to and stored by Google on servers in the United States. Apply for general-and-administrative jobs at Regeneron. Dr. Lowy is a licensed physician and has been board certified in internal medicine and infectious diseases. Dr. Soltys received his BS in Microbiology from Rutgers University and his PhD in Pharmacology/Toxicology jointly from Rutgers and the University of Medicine and Dentistry of New Jersey, and has been board-certified in Toxicology. Uncover why Regeneron is the best company for you. Learn about Regeneron culture, salaries, benefits, work-life balance, management, job security, and more. Sally A. Paull joined Regeneron as Senior Vice President, Human Resources in 2016. Dr. Coles served as President, Chief Executive Officer and Chairman of the Board of Onyx Pharmaceuticals, Inc., a biopharmaceutical company, from 2012 until 2013, having served as its President, Chief Executive Officer and a member of its board of directors from 2008 until 2012. Huda Y. Zoghbi, MD, joined the board in 2016. Dr. Yancopoulos was the 11th most highly cited scientist in the world in the 1990s, and in 2004 he was elected to be a member of the National Academy of Sciences. He is a primary architect of Regeneron’s cancer immunotherapy program. See if you qualify! Ms. Gilooly earned a BS in Biology from the University of Massachusetts. Robert E. Landry joined Regeneron in 2013 and serves as Executive Vice President, Finance and Chief Financial Officer. She holds a BS in Biology from the State University of New York at Binghamton and an MS in Neuroscience from New York University. Ms. Poon is on the Board of Directors of Prudential Financial, Inc. and the Supervisory Board of Royal Philips Electronics. Earlier in her career, Ms. Paull served in progressively senior human resources roles at DENYSPLY International. He earned his BS from Virginia Polytechnic Institute and State University. Arthur F. Ryan has been a Director of the company since January 2003. Prior to joining Johnson & Johnson, she spent 15 years at Bristol-Myers Squibb. Is this particular position a good fit? Before this, Dr. Reinertsen served as the Vice President of Corporate Development at Vertex Pharmaceuticals. Full-time. Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Maya Bermingham, JD, joined Regeneron in 2015 and serves as Senior Vice President, Public Policy and Government Affairs. All Job Titles R&D Associate (Histopathology) (3) Global Development Process & Procedures Head (3) Process and Procedures Business Partner - Associate Director (3) Medical Specialist, Immunology Dermatology Sales - Seattle N, WA (3) Medical Specialist (Pulmonology) - Suffolk, NY (3) Medical Specialist, Immunology Dermatology Sales - Roanoke, VA (3) Manager, Site Contracts (3) Assoc. He received post graduate clinical training in OBGYN and Gynecologic Oncology at the University of Cambridge and Duke University Medical Center. Goldstein and Brown jointly received the Nobel Prize for Physiology or Medicine in 1985. $150K. Get hired. Smita Pillai joined Regeneron as our first Chief Diversity, Equity & Inclusion (DE&I) Officer in 2021. Ms. Holly received a BS from Cornell University and a JD degree from Fordham Law School. Reviews from Regeneron employees about working as an Associate Manager at Regeneron. Regeneron Inc pays its employees an average of $95,509 a year. Commercial at Regeneron Pharmaceuticals Prior to joining Regeneron, Mr. O’Leary has worked as an independent consultant and at Pulmatrix, Alkermes, Organogenesis and Merck Serono. Dr. Tessier-Lavigne, a leader in the field of brain development, is a member of the National Academy of Sciences and its Institute of Medicine and a fellow of the Royal Societies of the United Kingdom and Canada. Neil Stahl, PhD, joined Regeneron in 1991 and has served as Executive Vice President, Research and Development since January 2015. Prior to Regeneron, Mr. Carreau worked at Novartis (formerly Chiron Corporation). Carver earned his BS in Chemical Engineering from the University of Nevada, Reno and his PhD in Chemical Engineering from Iowa State University. Ms. Poon is a Professor in the Department of Management and Human Resources at The Max M. Fisher College of Business at The Ohio State University, where she served as Dean and the John W. Berry, Sr. Dr. Thurston received his BS in Physics at Yale University and his PhD in Biophysics from the University of British Columbia. Gerald Underwood joined Regeneron in 1995 and serves as Senior Vice President, Technical Operations for the global Industrial Operations & Product Supply organization. Prior to joining Regeneron, Ms. Tegan worked at Ciba Specialty Chemicals and then as Senior Director/Head of Procurement at Purdue Pharma L.P., where she held roles of increasing responsibility. Johnathan M. Lancaster, MD, PhD, joined Regeneron in 2019 as a Vice President and now serves as SVP and Head of Global Medical Affairs. Previously, he held roles and responsibilities at Regeneron across R&D and business development. Kerry Reinertsen, PhD, joined Regeneron in 2011 and serves as Senior Vice President of Strategic Alliances. Marc Tessier-Lavigne, PhD, has been a Director of the company since November 2011. He graduated from Cornell University and earned his MD and PhD in Pharmacology from the University of Virginia. If using Safari, Quicktime is required. In 2008, Mr. Ryan retired as the Chairman and Chief Executive Officer of Prudential Financial, Inc., one of the largest diversified financial institutions in the world. He now serves as Senior Vice President of Oncology Research, and leads the company’s cancer research efforts, including targeting tumor cells with an expanding library of bispecific and costimulatory bispecific antibodies. Hala Mirza joined Regeneron in 2014 and serves as Senior Vice President, Corporate Communications and Citizenship, leading corporate reputation, internal and external communications, patient advocacy and corporate citizenship. Bob McCowan is Senior Vice President and Chief Information Officer at Regeneron. From 2008 to 2013, Mr. Ryan served as a non-executive director of the Royal Bank of Scotland Group plc. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Prior to joining Regeneron, he held senior leadership positions in Drug Safety Assessment at Genentech and Bristol-Myers Squibb. She has been elected to the National Academy of Sciences, the American Academy of Arts and Sciences, the Royal Society and the American Philosophical Society and has received many scientific honors, including a MacArthur Foundation Fellowship, the Lounsbery Award and the Shaw Prize for Life Science and Medicine. Previously, he served in roles of increasing responsibility at Merck, most recently as the Vice President and Head, Early Stage Development. Copyright © 2021 Regeneron Pharmaceuticals Inc. All rights reserved. Dr. Schleifer has been recognized as one of Barron’s Best CEOs and as an Ernst & Young Entrepreneur of the Year. We also do not hire for “at-home data entry” positions. He holds a BBA in Accounting from the University of Notre Dame. Drs. He received his AB in Biochemical Sciences from Princeton University and his MD-PhD in Biochemistry and Molecular Biophysics from Columbia University. The average Regeneron salary ranges from approximately $50,000 per year for Warehouse Worker to $293,497 per year for Senior Clinical Manager. Thank you for reaching out to us. Regeneron Pharmaceuticals Careers Manager, Site Budgets Jobs in United States Featured Jobs; Manager, Site Budgets. Daniel Van Plew joined Regeneron in 2007 and has served as Executive Vice President and General Manager, Industrial Operations and Product Supply since January 2016. Scott Carver, PhD, joined Regeneron in 1998 and serves as Senior Vice President, Manufacturing and Process Sciences. Regeneron Careers – District Manager. He joined Merck in 1975, became a director in 1984, President and Chief Executive Officer in 1985 and Chairman in 1986. Cookies are small text files which are automatically placed on your computer by the internet browser when you visit the Sites. Select your job title and find out how much you could make at Regeneron Pharmaceuticals. Dr. Murphy is a co-inventor of several of Regeneron's key technologies, VelociGene® and VelocImmune®, and continues to lead several Technology Centers and Therapeutic Focus Areas. She received her BS from the United States Air Force Academy and her Master’s in International Relations from the University of Delaware. She was previously at Pfizer where she held the positions of Vice President, Business Operations and Analytics, and, prior to that, Vice President, Strategic Alliance and Development Operations Lead. Gregory Geba, MD, PhD, joined Regeneron in 2013 and serves as Senior Vice President of the Global Development Scientific Council, a group that provides senior scientific input to Regeneron’s therapeutic portfolio of programs. Dr. Yancopoulos, along with key members of his team, is the principal inventor of Regeneron’s eight FDA-approved drugs and foundational technologies, including the TRAP technology, VelociGene® and VelocImmune®. Previously, Dr. Olson was a scientist at MicroGeneSys and Johnson & Johnson’s RW Johnson Pharmaceutical Research Institute. A cookie can, amongst other things, track the web pages you visit and the options you use. 2 salaries (for 2 job titles) Updated Jan 27, 2021 2 Regeneron Pharmaceuticals employees have shared their salaries on Glassdoor. From 1998 until 2004, he held various managerial positions in the health and life sciences practice at Accenture, Ltd., a management consulting business. Compare pay for popular roles and read about the team’s work-life balance. He is a physician-scientist with decades of experience in design, execution and analysis of clinical trials. Prior to joining Regeneron, Dr. Stahl received his BS degree from Duke University and his PhD in Biochemistry from Brandeis University, then conducted post-doctoral research and was a faculty member at the University of California, San Francisco. Sing has also served as Chief Executive Officer of Stemnion, Inc., a biomedical company in the regenerative medicine field. Dr. Yancopoulos, together with key members of his team, is a principal inventor and developer of Regeneron's seven FDA-approved drugs, as well as its foundational technologies, including the Trap technology, VelociGene® and VelocImmune®. Regeneron Inc employees with the job … Ned Braunstein, MD, joined Regeneron in 2009, and serves as Senior Vice President, Regulatory Affairs, Global Patient Safety. He obtained his JD from Columbia University Law School, where he was a Harlan Fisk Stone Scholar, and his PhD from the Integrated Program in Cellular, Molecular and Biophysical Studies at the Columbia University Graduate School of Arts and Sciences, where he received the Richard C. Parker Award for Outstanding and Innovative Research and a Minority Pre-doctoral Fellowship Award. P. Roy Vagelos, MD, has been Chairman of the Board of the company since January 1995. 535 Regeneron Pharmaceuticals jobs, including salaries, reviews, and other job information posted anonymously by Regeneron Pharmaceuticals employees. Continue Reading Dr. Goldstein has been Professor of Medicine and Genetics and Chairman of the Department of Molecular Genetics at The University of Texas Southwestern Medical Center at Dallas since 1977. Joseph J. LaRosa joined Regeneron in 2011 and is currently Executive Vice President, General Counsel and Secretary. 123 Regeneron jobs available in Rensselaer, NY on Indeed.com. He also serves on the Boards of Trustees of The Rockefeller University and the Howard Hughes Medical Institute. He has been named an Ernst & Young Entrepreneur of the Year and has been pivotal in creating the science-driven, collaborative and highly-productive R&D culture at Regeneron. Dr. Brown holds the Distinguished Chair in Biomedical Sciences, a position he has held since 1989, is a Regental Professor of Molecular Genetics and Internal Medicine and the Director of the Erik Jonsson Center for Molecular Genetics and Human Disease at the University of Texas Southwestern Medical Center at Dallas, positions he has held since 1985. Andrew Murphy, PhD, joined Regeneron in 1999 as Director of Genomics and Bioinformatics and is now Executive Vice President of Research. $100K. Dr. Braunstein received his BS in Medicine and his MD from Northwestern University. Regeneron Pharmaceuticals, Inc. and its affiliates, Regeneron Ireland Unlimited Company and Regeneron UK Limited (together, "Regeneron", "we", "us" or "our") use this data to make the Sites more user-friendly and efficient. View job description, responsibilities and qualifications. Regeneron is a place where new ideas are welcome. Dr. Weinreich also previously served as Vice President of Clinical Affairs at Gene Logic and as an independent consultant, helping small to mid-stage biotechnology companies with drug commercialization. Prior to joining Regeneron, Dr. Baras contributed to other biotechnology ventures and conducted research spanning antibody-based therapeutics, cancer research and nanotechnology applications in drug development. Mr. Van Plew received his MS in Chemistry from Penn State University and his MBA from Michigan State University. With over 30 years global experience, Mr. McCowan leads the company’s IT organization and is responsible for global IT strategy supporting Research, Commercial, Cyber Security and Enterprise operations. why Regeneron, your related background, why you're a good fit). He is responsible for protecting Regeneron’s Intellectual Property, including by developing and implementing a comprehensive global IP strategy. He has prior experience in healthcare industry-focused venture capital and investment banking roles, as well as serving as an audit senior at KPMG. Prior to his current role, he served as Regeneron’s Vice President of Financial Planning, and prior to joining Regeneron, he was Vice President of Finance at Mojave Therapeutics, Inc. Before that, he was Assistant Professor of Medicine and Microbiology at Mount Sinai School of Medicine. The site you are about to visit is maintained by a third party who is solely responsible for its content. Know about a career with Regeneron and Search for the Jobs in Research and Development, Commercial and more! Our goal is to address serious medical conditions, across multiple and diverse therapeutic areas. Dr. Zoghbi is currently a professor in the departments of Pediatrics, Molecular and Human Genetics, and Neurology and Neuroscience at Baylor College of Medicine, the director of the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital and an investigator of the Howard Hughes Medical Institute.